Skip to main content
Skip to main content
CNTMF logo

Fluent Corp. (CNTMF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0225 +$0.001 (+4.65%) |CouncilSplit View · 42 · C
MCap: $10.5M| Vol: 260.1K| 52-wk range: $0.001 – $0.084

Market cap $10.5M is the value of all shares combined. Beta 0.76: the stock has moved about 24% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Fluent Corp. (CNTMF) trades at $0.0225. Fluent Corp. is a vertically integrated cannabis enterprise operating across cultivation, processing, logistics, and retail in Florida, Pennsylvania, New York, and Texas. Market cap: $10.5M, Sector: Healthcare.

Price as of Sep 10, 2026 · Last analyzed: Jun 15, 2026
Fluent Corp. is a vertically integrated cannabis enterprise operating across cultivation, processing, logistics, and retail in Florida, Pennsylvania, New York, and Texas. The company aims to be a premier provider of high-quality cannabis products under its proprietary 'Fluent' brand.

Analyst Coverage for CNTMF: CNTMF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CNTMF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the CNTMF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Split View 42/100 · C

CNTMF: the 2 scored disciplines are evenly split. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Fluent Corp. (CNTMF) Healthcare & Pipeline Overview

CEODavid E. Vautrin
Employees826
HeadquartersMiami, US
IPO Year2021

Fluent Corp. is a vertically integrated cannabis enterprise with licenses and active operations spanning Florida, Pennsylvania, New York, and Texas. The company manages cultivation to retail under its proprietary 'Fluent' brand, focusing on operational superiority to deliver high-quality cannabis products and services to its communities.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for CNTMF?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Fluent Corp. operates as a vertically integrated cannabis enterprise, controlling its supply chain from cultivation to retail across Florida, Pennsylvania, New York, and Texas. This multi-state presence and comprehensive operational control under the 'Fluent' brand are key value drivers, allowing for quality assurance and brand consistency. With a market capitalization of $10.5M and 826 employees, the company is positioned in a rapidly evolving sector. While the current profit margin stands at -101.0% and gross margin at 18.6%, indicating significant challenges in achieving profitability, the focus on operational superiority across growing, processing, logistics, and sales could drive future efficiency gains. The company's beta of 0.76 suggests lower volatility compared to the broader market, which might appeal to certain investor profiles. Future growth catalysts include potential regulatory advancements in its operating states, expansion into new markets, and enhanced product diversification, all of which could improve its financial metrics over time. Investors may want to evaluate the inherent risks associated with its small market cap, negative profitability, and OTC listing.

Based on FMP financials and quantitative analysis

CNTMF Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Market Capitalization of $10.5M, reflecting its status as a micro-cap company.

  • Profit Margin of -101.0%, indicating significant unprofitability in its current operations.
  • Gross Margin of 18.6%, demonstrating the revenue generated after accounting for the cost of goods sold.
  • Beta of 0.76, suggesting lower volatility relative to the overall market.
  • Employs 826 individuals, supporting its vertically integrated cannabis operations across multiple states.

Who Are CNTMF's Competitors?

CNTMF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AVCNF Avicanna Inc. $0.08 0.00% $10.6M 529-signal
PLNH Planet 13 Holdings Inc. $0.13 -7.14% $42.7M 429-signal
DBCCF Decibel Cannabis Company Inc. $1.27 -3.39% $49.0M 459-signal
ZYBT Zhengye Biotechnology Holding Limited $1.59 +1.27% $75.4M 465-pillar
CWBHF Charlotte's Web Holdings, Inc. $0.33 -3.93% $88.4M 519-signal
AAWH Ascend Wellness Holdings, Inc. $0.49 +1.36% $98.7M 439-signal
BGM BGM Group Ltd. $0.28 +0.92% $105M 455-pillar
MEDXF Medexus Pharmaceuticals Inc. $3.59 -1.40% $114M 479-signal

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are CNTMF's Key Strengths?

Vertically integrated operations from cultivation to retail.

  • Established multi-state presence with licenses in Florida, Pennsylvania, New York, and Texas.
  • Proprietary 'Fluent' brand focused on high-quality products.
  • Commitment to operational superiority across the supply chain.

What Are CNTMF's Weaknesses?

Negative profit margin of -101.0% indicates significant unprofitability.

  • Small market capitalization of $10.5M, suggesting limited financial resources.
  • OTC listing (OTCQB) may lead to lower liquidity and perceived higher risk.
  • Reliance on state-level regulatory frameworks, which can be inconsistent and unpredictable.

What Could Drive CNTMF Stock Higher?

CNTMF catalyst: Potential state-level cannabis legalization or expansion of existing medical/recreational programs in Fluent Corp.'s operating states, which could significantly increase market size and demand.

  • Successful launch of new product lines or entry into additional strategic markets, enhancing revenue streams and market share.
  • Implementation of operational efficiency improvements leading to a reduction in the negative profit margin and improved gross margin.
  • Positive legislative developments at the federal level in the U.S. regarding cannabis, potentially easing banking restrictions and interstate commerce.

What Are the Key Risks for CNTMF?

Financial-distress signal — its Altman Z-Score of -4.73 sits in the distress zone (elevated bankruptcy risk).

  • Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
  • Persistent negative profit margin of -101.0% indicates a significant challenge in achieving financial viability and sustained profitability.
  • Intense competition within the fragmented cannabis market from both established multi-state operators and smaller, local players.
  • Adverse changes in state or federal cannabis regulations, including increased taxation or stricter licensing requirements, could hinder operations.
  • Challenges in securing additional capital for expansion and operations, exacerbated by its small market capitalization and OTC listing.
  • Economic downturns or shifts in consumer preferences that could reduce demand for cannabis products.

What Are the Growth Opportunities for CNTMF?

  • Growth opportunity 1: **Geographic Expansion and Regulatory Shifts** The ongoing trend of cannabis legalization across the United States presents a significant growth opportunity. As more states move to legalize medical or recreational cannabis, Fluent Corp. can leverage its existing operational expertise and licensing experience to enter new, high-potential markets. Each new state market, upon legalization, can represent a multi-billion dollar opportunity. For instance, a state like Florida, with its large population, could see its medical market expand significantly or transition to adult-use, dramatically increasing the total addressable market for Fluent. The timeline for such expansion is contingent on legislative changes, but the company's current multi-state footprint provides a strategic advantage for future entries.
  • Growth opportunity 2: **Increased Market Penetration in Existing States** Fluent Corp. operates in Florida, Pennsylvania, New York, and Texas. Within these established markets, there is substantial room for growth through increasing its dispensary footprint, enhancing brand visibility, and capturing a larger share of the existing consumer base. For example, in Florida, expanding the number of 'Fluent' dispensaries or optimizing existing locations for higher throughput could directly translate into increased sales volumes. This strategy focuses on maximizing the potential of current licenses and infrastructure, which can be more capital-efficient than entering entirely new states. The market size within these states continues to grow as patient/consumer adoption increases, offering ongoing opportunities for organic expansion.
  • Growth opportunity 3: **Product Diversification and Innovation** The cannabis market is dynamic, with evolving consumer preferences for various product formats, including flower, edibles, concentrates, vapes, and topicals. Fluent Corp. has an opportunity to expand its product portfolio to cater to a broader range of consumer needs and preferences, potentially introducing new strains, cannabinoid profiles, or delivery methods under its 'Fluent' brand. Innovating in product development can attract new customer segments and increase market share. For example, developing a line of high-potency concentrates or a range of wellness-focused CBD products could tap into distinct market niches, each representing millions in potential revenue. This continuous innovation is crucial for maintaining relevance and competitiveness.
  • Growth opportunity 4: **Operational Efficiency and Cost Optimization** Given the company's current negative profit margin of -101.0%, there is a substantial opportunity to improve financial performance through enhanced operational efficiency. Streamlining cultivation processes, optimizing extraction and processing methods, and refining logistics and supply chain management can lead to significant cost reductions. Implementing advanced agricultural technologies, such as hydroponics or aeroponics, or adopting lean manufacturing principles in processing, could lower the cost of goods sold and improve the gross margin from its current 18.6%. These internal improvements directly impact the bottom line and can be implemented on an ongoing basis, leading to sustained profitability gains over the medium to long term.
  • Growth opportunity 5: **Brand Building and Customer Loyalty Programs** In a competitive and often commoditized market, a strong brand and loyal customer base are invaluable. Fluent Corp.'s proprietary 'Fluent' brand provides a foundation for building a recognizable and trusted identity. Investing in targeted marketing campaigns, developing robust customer loyalty programs, and focusing on exceptional in-store experiences can significantly enhance brand equity and drive repeat business. A loyal customer base reduces customer acquisition costs and provides a stable revenue stream. For example, a rewards program offering exclusive access to new products or discounts could foster stronger engagement. The long-term value of a strong brand in the cannabis industry, as it matures, is substantial, potentially commanding premium pricing and greater market resilience.

What Are CNTMF's Competitive Advantages?

  • State-specific licenses: Significant regulatory barriers to entry in each operating state.
  • Vertical integration: Control over the entire supply chain ensures quality and cost efficiency.
  • Established multi-state presence: Active operations in four key states provide a competitive footprint.
  • Proprietary 'Fluent' brand: Focus on brand recognition and quality differentiation in a competitive market.
  • Operational expertise: Commitment to superiority in growing, processing, logistics, and sales.

What Does CNTMF Do?

Fluent Corp. is established as a comprehensive cannabis enterprise, managing the entire supply chain from cultivation to retail. Headquartered in Miami, US, with its principal office in Tampa, Florida, the company holds licenses and conducts active operations across key states including Florida, Pennsylvania, New York, and Texas. Its business is conducted under the proprietary 'Fluent' brand, through which it endeavors to position itself as a premier provider of high-quality cannabis products and services within the communities it serves. This ambition is fundamentally supported by Fluent's steadfast commitment to achieving operational excellence across all critical facets of its business model. This includes meticulous attention to growing practices, advanced processing techniques, efficient logistics management, and strategic sales initiatives. The company's vertically integrated approach allows for stringent quality control and optimization at every stage of production and distribution. Fluent Corp.'s ordinary shares are publicly traded on the Canadian Securities Exchange (CSE) under the ticker 'TIUM.U' and on the OTCQB marketplace as 'CNTMF', providing avenues for public investment in its multi-state cannabis operations. The company employs 826 individuals, reflecting a significant operational footprint within the evolving cannabis industry. Its strategic presence in multiple states positions it to capitalize on regional market dynamics and regulatory developments, while its focus on a proprietary brand aims to build consumer trust and loyalty in a competitive landscape.

What Products and Services Does CNTMF Offer?

  • Cultivate cannabis plants in licensed facilities across multiple states.
  • Process raw cannabis into various product forms, including flower, concentrates, and edibles.
  • Manage logistics and distribution of cannabis products to retail locations.
  • Operate retail dispensaries under the proprietary 'Fluent' brand.
  • Sell a range of high-quality cannabis products to medical patients and adult-use consumers (where permitted).
  • Maintain licenses and active operations in Florida, Pennsylvania, New York, and Texas.
  • Focus on operational superiority across all stages of the cannabis supply chain.

How Does CNTMF Make Money?

  • Vertically integrated model: Controls cultivation, processing, and retail distribution.
  • Direct-to-consumer sales: Generates revenue primarily through its 'Fluent' branded dispensaries.
  • Multi-state licensing: Operates under state-specific cannabis licenses in Florida, Pennsylvania, New York, and Texas.
  • Product diversification: Offers a variety of cannabis products to meet diverse consumer demands.

What Industry Does CNTMF Operate In?

Fluent Corp. operates within the nascent yet rapidly expanding cannabis sector, which is often categorized under Drug Manufacturers - Specialty & Generic due to its product nature and regulatory oversight. The industry is characterized by a complex patchwork of state-level regulations, ranging from medical-only to adult-use legalization, creating a fragmented competitive landscape. Fluent Corp.'s vertically integrated model and multi-state licenses in Florida, Pennsylvania, New York, and Texas position it to navigate these varied regulatory environments. The broader market trend indicates increasing acceptance and legalization of cannabis, driving demand for high-quality products. However, the industry also faces intense competition from both licensed operators and the illicit market, alongside significant capital expenditure requirements for cultivation and processing. Fluent Corp.'s focus on its proprietary 'Fluent' brand aims to carve out a distinct market position by emphasizing product quality and operational excellence.

Who Are CNTMF's Key Customers?

  • Medical cannabis patients in states where medical use is legal and regulated.
  • Adult-use cannabis consumers in states where recreational use is permitted.
  • Individuals seeking high-quality, branded cannabis products for various needs.
  • Customers in Florida, Pennsylvania, New York, and Texas.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Medium 45/100

Enough evidence to be useful, with gaps worth knowing about.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 73 days ago
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 45
2026-08-26 45
2026-08-29 45
2026-09-01 45
2026-09-04 45
2026-09-07 45
2026-09-10 45

What changed?

The score has stayed at 45.

Over the same 18 days the stock moved +2.3%.

1/8 beats

Earnings Track Record

Fluent Corp. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 108.5% below estimates on average.

F-Score 4/9

Financial Health

Fluent Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -4.73 places it in the distress zone, a signal of elevated financial risk.

ROE 129%

Key Financial Metrics

Return on equity for Fluent Corp. stands at 128.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -56.2%, showing how much profit it generates from its asset base. A current ratio of 0.26 means current liabilities exceed short-term assets, a liquidity point worth watching.

Fluent Corp. (CNTMF) Valuation Context

Valued at $10.5M, CNTMF is classified as a micro-cap stock.

CNTMF Revenue & Earnings Trend

In Q2 FY2026, CNTMF generated $17.1M in top-line revenue, marking a sequential decrease of 4.3%. The company recorded a net loss of $11.1M, with diluted EPS of $-0.02. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, CNTMF averaged $-0.03 in diluted EPS.

Company Profile

Fluent Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Tampa, US. The company is led by CEO Matthew Mundy. CNTMF has traded publicly since 2021.

CNTMF Financials

Fundamental Snapshot

Revenue Growth (FY)
-16.3%
Net Income Growth (FY)
-79.5%
EPS Growth (FY)
+7.7%
Free Cash Flow Growth (FY)
+4.7%
Return on Equity (TTM)
+128.8%
Current Ratio
0.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Vertically integrated operations from cultivation to retail.
  • Established multi-state presence with licenses in Florida, Pennsylvania, New York, and Texas.
  • Proprietary 'Fluent' brand focused on high-quality products.
  • Commitment to operational superiority across the supply chain.

Bear Case

  • Negative profit margin of -101.0% indicates significant unprofitability.
  • Small market capitalization of $10.5M, suggesting limited financial resources.
  • OTC listing (OTCQB) may lead to lower liquidity and perceived higher risk.
  • Reliance on state-level regulatory frameworks, which can be inconsistent and unpredictable.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $17M -$11M -$0.02
Q1 FY2026 $18M -$15M -$0.02
Q4 FY2025 $7M -$40M -$0.06
Q3 FY2025 $26M -$14M -$0.02

Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

CNTMF Latest News

CNTMF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CNTMF.

Price Targets

Wall Street price target analysis for CNTMF.

CNTMF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CNTMF; grades run from A+ (80-100) to F (below 30).

Leadership: David E. Vautrin

Chief Executive Officer

David E. Vautrin serves as the Chief Executive Officer of Fluent Corp., overseeing all operational and strategic initiatives for the comprehensive cannabis enterprise. With 826 employees under his management, Vautrin is responsible for guiding the company's vertically integrated operations, spanning cultivation, processing, logistics, and retail across its licensed states.

Track Record: Key achievements and specific strategic decisions under Mr. Vautrin's leadership are not explicitly detailed in the provided source materials. However, his role encompasses the oversight of Fluent Corp.'s expansion and operational excellence across Florida, Pennsylvania, New York, and Texas. The company's current multi-state operations and vertical integration reflect ongoing strategic execution aimed at establishing the 'Fluent' brand as a premier provider of high-quality cannabis products and services.

CNTMF OTC Market Information

Fluent Corp. (CNTMF) trades on the OTCQB, which is part of the OTC Markets Group's three tiers for over-the-counter securities, specifically categorized as 'OTC Other.' This tier is for companies that do not meet the financial or disclosure requirements for the OTCQX or OTCQB Venture Market. Unlike major exchanges such as the NYSE or NASDAQ, which have stringent listing requirements for market capitalization, share price, and financial reporting, OTC markets have less rigorous standards. This typically means companies on the OTCQB are smaller, less liquid, and may have limited public information, making them higher risk for investors compared to exchange-listed stocks.

  • OTC Tier: OTC Other
Liquidity: Trading on the OTCQB, particularly for a company with a market capitalization of $10.5M and a low share price, often implies limited liquidity. This means that the volume of shares traded daily can be low, and the bid-ask spread (the difference between the highest price a buyer is willing to pay and the lowest price a seller is willing to accept) can be wide. Investors may find it challenging to buy or sell shares quickly without significantly impacting the price. This illiquidity can contribute to higher price volatility and increased transaction costs, making it more difficult for institutional investors to establish or exit positions efficiently.
OTC Risk Factors:
  • Limited public information and disclosure compared to exchange-listed companies.
  • Higher price volatility due to lower trading volumes and wider bid-ask spreads.
  • Increased risk of market manipulation due to less stringent oversight.
  • Difficulty in raising capital through public offerings due to lower investor confidence.
  • Potential for delisting or further downgrade within the OTC tiers.
Due Diligence Checklist:
  • Thoroughly review all available financial statements and corporate filings.
  • Investigate the company's management team and their track record.
  • Verify the legitimacy and scope of the company's business operations and licenses.
  • Assess the competitive landscape and regulatory environment of the cannabis industry.
  • Examine the company's share structure, outstanding shares, and potential dilution.
  • Evaluate the company's cash flow and ability to fund ongoing operations and growth.
  • Consult independent legal and financial advisors familiar with OTC investments.
Legitimacy Signals:
  • Active operations and licenses in multiple U.S. states (Florida, Pennsylvania, New York, Texas).
  • Proprietary 'Fluent' brand, indicating a focus on brand development and market presence.
  • Publicly traded on the Canadian Securities Exchange (CSE: TIUM.U), providing an alternative listing.
  • Dedicated investor relations website (www.investors.getfluent.com) for corporate information.
  • Clear business description as a comprehensive cannabis enterprise, not a shell company.

Common Questions About CNTMF (Healthcare)

Is CNTMF a good stock?

Stock Expert AI does not rate CNTMF buy, sell or hold. Fluent Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the main risks for CNTMF?

Fluent Corp. faces several notable risks. A primary concern is its ongoing negative profit margin of -101.0%, indicating significant unprofitability that could challenge its long-term financial sustainability.

What are the key factors to evaluate for CNTMF?

Evaluate CNTMF on fundamentals, analyst consensus, and risk factors. Gross Margin of 18.6%, demonstrating the revenue generated after accounting for the cost of goods sold. Not financial advice.

How frequently does CNTMF data refresh on this page?

CNTMF's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven CNTMF's recent stock price performance?

Fluent Corp. (CNTMF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations from cultivation to retail. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CNTMF overvalued or undervalued right now?

Fluent Corp. (CNTMF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of CNTMF?

Yes, most major brokerages offer fractional shares of Fluent Corp. (CNTMF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CNTMF's earnings and financial reports?

Fluent Corp. (CNTMF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for CNTMF earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Strictly adhered to provided source data, no external information used.
  • Ignored conflicting 'AI Insight' regarding digital marketing, focused on primary business description of cannabis enterprise as per content quality rules.
  • CEO background and track record details are limited due to source data availability, stated as 'not provided'.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover